Pasithea Therapeutics enters new CEO employment agreement with Tiago Reis Marques

Pasithea Therapeutics Corp.

Base salary $450,000; sign-on bonus $100,000 lump sum after Jan 1, 2022.
Annual discretionary bonus up to 75% of base salary.
Equity grants: 200,000 RSUs and 200,000 options vesting over 3 years (33% after 12 months, then quarterly).
Severance: 12 months base salary if terminated without cause, subject to separation agreement.
Agreement effective January 1, 2022; Board approved equity grants on Dec 20, 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.